When supply couldnt meet demand, compounders began producing alternativessome with legitimate sourcing and clinical rigor, others in clear violation of FDA guidance
Safety and Effects of Anti-Obesity Medications on Weight Loss, Cardiometabolic, and Psychological Outcomes in People Living with Overweight or Obesity: A Systematic Review and Meta-Analysis
First of all, the distinction between weight loss on a normal diet and protection from weight gain in a high fat diet is a tricky one, because its hard to tell if the latter actually qualifies for our final goal, which is presumably will an obese person taking this lose weight?
The cost per dose may change
[1] [9] Sermorelin , by contrast, was FDA-approved decades ago (Geref, 1997) but the manufacturer voluntarily withdrew it in 2008, and the FDA determined that withdrawal was not for reasons of safety or effectiveness